Egalet News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

07.06.18	Egalet Appoints Industry Veteran John Varian to Board of Directors (PR Newswire)
04.06.18	Egalet to Participate in Panels at 2018 BIO International Convention and JMP Life Sciences Conference (PR Newswire)
29.05.18	Egalet Announces Large Regional Plan to Cover SPRIX® Nasal Spray (PR Newswire)
08.05.18	Egalet Reports First Quarter 2018 Financial Results (PR Newswire)
07.05.18	Egalet Announces National Pharmacy Benefit Manager to Cover SPRIX® Nasal Spray and ARYMO® ER (PR Newswire)
30.04.18	Egalet Presented Data at American Academy of Pain Medicine Examining the Potential of ARYMO® ER to Deter Opioid Abuse (PR Newswire)
24.04.18	Egalet to Host Conference Call and Webcast to Discuss First Quarter 2018 Financial Results on May 8, 2018 (PR Newswire)
17.04.18	Egalet Announces Two Large Northeast Regional Health Plans Placed ARYMO® ER in Preferred Formulary Position (PR Newswire)
12.04.18	AIG and EY Announce Strategic Tax Compliance and Technology Agreement (PR Newswire)
21.03.18	Egalet to Present at Upcoming Conferences (PR Newswire)
12.03.18	Egalet Reports Fourth Quarter and Full Year 2017 Financial Results (PR Newswire)
28.02.18	Egalet Announces a Large Regional Health Plan Placed ARYMO® ER and SPRIX® Nasal Spray in Preferred Formulary Positions (PR Newswire)
26.02.18	Egalet to Host Conference Call and Webcast to Discuss Fourth Quarter and Year-End 2017 Financial Results on March 12, 2018 (PR Newswire)
20.02.18	Egalet Announces Issuance of New U.S. Patent for Guardian™ Technology (PR Newswire)
01.02.18	Egalet to Participate in Panel at BIO CEO & Investor Conference (PR Newswire)
29.01.18	Egalet Announces ARYMO® ER Data Published in Current Medical Research and Opinion Journal (PR Newswire)
24.01.18	Egalet to Co-Host Category 1 Focus Group (PR Newswire)
23.01.18	Egalet's Partner OraPharma Begins Promotion of SPRIX® Nasal Spray (PR Newswire)
03.01.18	Egalet Partners with OraPharma to Co-Promote SPRIX® Nasal Spray (PR Newswire)
20.12.17	Scientific Games and NYX Gaming Group Announce Shareholder Approval for Acquisition of NYX (PR Newswire)
20.12.17	Egalet Reduces Debt Obligation, Extends Maturity and Lowers Annual Interest Payments through Refinancing of Existing Convertible Notes (PR Newswire)
18.12.17	FDA Nod For ACRS, PETX Disappoints, QGEN & OXFD Make Peace, SGRY Fitter (RTTNews)
15.12.17	Egalet Receives FDA Tentative Approval for Expanded Label for ARYMO® ER (morphine sulfate) C-II, an Extended-Release Morphine Product Formulated with Abuse-Deterrent Properties for Treatment of... (PR Newswire)
29.11.17	EARS Pinched By HEALOS Data, EGLT Does It Again, JAVELIN Gastric 300 Misses Mark (RTTNews)
28.11.17	Egalet Announces Positive Top-Line Results from Phase 3 Study Evaluating Efficacy and Safety of Egalet-002 in Patients with Moderate-to-Severe Chronic Low Back Pain (PR Newswire)
20.11.17	Daiichi Sankyo, Inc. Launches CommitmentsinPainCare.com (PR Newswire)
20.11.17	Egalet Received a Grant from InnoBooster to Develop a Novel Application of Guardian™ Technology (PR Newswire)
17.11.17	Newly Rebranded Clique Staffs Up (PR Newswire)
17.11.17	FDA Nod For Label Expansion Of Sutent, Egalet Flies, Double Blessing For Roche (RTTNews)
16.11.17	Egalet Announces Positive Top-Line Results from Phase 3 Safety Study Evaluating Safety of Egalet-002 (PR Newswire)
08.11.17	Egalet Announces Third Quarter 2017 Financial Results (PR Newswire)
06.11.17	Egalet Announces ARYMO ER Added to Large Payer Medicare Part D Formulary (PR Newswire)
30.10.17	Egalet to Present at Upcoming Scientific and Investor Conferences (PR Newswire)
25.10.17	Egalet to Host Conference Call and Webcast to Discuss Third Quarter 2017 Financial Results on November 8, 2017 (PR Newswire)
20.10.17	National Press Club Examines 2016 Russian Election Hacking at a Headliners Book Rap Featuring Donna Brazile on December 12th (PR Newswire)
18.09.17	National Lacrosse League and Egalet Corporation Announce Educational Partnership Around A Non-Narcotic Pain Option and Responsible Pain Management (PR Newswire)
15.09.17	John Paul Ataker's "Slow Fashion" SS18 Collection Featured Karlie Kloss, Taylor Hill at NYFW in Anticipation of First U.S. Store Opening (PR Newswire)
13.09.17	Stocks Under Scanner in the Biotech Space -- Curis, Egalet, and Esperion Therapeutics (PR Newswire)
12.09.17	Government enforcement speakers join with compliance and legal experts at the HCCA's 3rd Annual Healthcare Enforcement Compliance Institute (PR Newswire)
08.09.17	Egalet Presented New Data at PAINWEEK Demonstrating Potential of ARYMO ER to Deter Opioid Abuse (PR Newswire)
06.09.17	Egalet to Present at Investor Conferences this Fall (PR Newswire)
05.09.17	Egalet's Partner Ascend Therapeutics® U.S., LLC Begins Promotion of SPRIX® Nasal Spray (PR Newswire)
24.08.17	Vertical Booking Increases Its Reach in North America (PR Newswire)
09.08.17	Egalet Announces Second Quarter 2017 Financial Results and Expense Reduction Plan (PR Newswire)
04.08.17	Green Alley: Triclosan, Banned by the U.S. F.D.A., Remains in Various Personal Care Products (PR Newswire)
18.07.17	Today's Research Report Coverage on Biotech Stocks -- Eleven Biotherapeutics, Egalet, Aevi Genomic Medicine, and INSYS Therapeutics (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sonova Hldg	295.60	0.96 %	K V
Lonza Grp	531.00	0.53 %	K V
Alcon	76.02	0.34 %	K V
Roche Hldg G	247.40	0.28 %	K V
ABB	48.86	0.27 %	K V
Swisscom	498.40	-0.62 %	K V
UBS Group	26.71	-0.67 %	K V
Zurich Insur Gr	533.00	-0.97 %	K V
Holcim	86.10	-1.01 %	K V
Sika	213.20	-2.47 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Egalet Corp

Aktien Top/Flop

Meistgelesene Nachrichten